/HSITF

HSITF Stock - Hadasit Bio-Holdings Ltd

Q: What is the analyst price target for HSITF?

Analyst price target information is not currently available for HSITF.

Q: What is HSITF's market cap?

Market capitalization information is not currently available for HSITF.

Healthcare|Biotechnology|OTC

$0.12+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.13

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for HSITF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.43

52W High$0.13

52W Low$0.12

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-1,702,000	$-1,781,000	$-2,732,000	$-2,083,000	$-2,293,000
Net Income	$-3,461,000	$-29,187,000	$-31,211,000	$28.36M	$31.22M
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$-0.31	$-2.63	$-2.81	$2.56	$2.82

Company Overview

Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It primarily focuses on the therapeutic areas, including oncology, regenerative medicine, and inflammatory disease. The company offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. Hadasit Bio-Holdings Ltd was founded in 2005 and is based in Jerusalem, Israel.

Visit Website

Frequently Asked Questions about HSITF

What is HSITF's current stock price?

Hadasit Bio-Holdings Ltd (HSITF) is currently trading at $0.12 per share. The stock has moved +0.00% today.

What is the analyst price target for HSITF?

No analyst price targets are currently available for this stock.

What sector is Hadasit Bio-Holdings Ltd in?

Hadasit Bio-Holdings Ltd operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.

What is HSITF's market cap?

Hadasit Bio-Holdings Ltd has a market capitalization of $0.00 billion, making it a small-cap company.

Does HSITF pay dividends?

No, Hadasit Bio-Holdings Ltd does not currently pay a dividend to shareholders.